Search bioRxiv⌕ Search

Biology subjects

Sturek, J. M.

Publications and source records attributed to Sturek, J. M..

8 recordsLinked to original sources

Computational Analysis of Fibroblast Subpopulation Dynamics as a Driver of Fibrotic Foci Formation

Fibroblasts maintain the extracellular matrix (ECM) to support tissue homeostasis and wound healing. In fibrotic diseases, fibroblasts are a primary driver of disease progression through excess collagen secretion and enhanced contractility. Replacing native tissue with a collagen rich fibrotic scar leads to a decline in tissue function. Recent research into idiopathic pulmonary fibrosis (IPF) has identified fibroblast subpopulations that may be primed for the hyper-activation that leads to increased progression of fibrotic disease. Understanding the contribution of these subpopulations to disease progression requires integrating experimental and computational techniques to understand their dynamic contributions to tissue phenotype. Herein, we introduce a framework for modeling subpopulations using a multiscale mechanistic computational model to understand differences within subpopulations, at the intracellular level and how these differences contribute to cell-and tissue-level pathology. We build and validate this framework using two well-defined subpopulations of fibroblasts in IPF. The subpopulations are defined by the presence or absence of Thy-1, a cell-surface protein that regulates fibroblast mechanosensing. We first developed a logic-based network model of a fibroblast. We then applied this model to identify sub-networks that regulate myofibroblast marker expression in the two subpopulations. Coupling this with an agent-based model (ABM) of the lung microenvironment, we observed how different rules regulating cell fate decisions in each subpopulation affected collagen content. Computational image outputs were analyzed with the open-source biological image analysis software QuPath to quantify how changes in subpopulation dynamics change model-predicted foci characteristics such as size and collagen density. We find that the ability for Thy-1+ fibroblasts to transition to Thy-1- fibroblasts significantly increases total collagen content, as well as influences fibrotic foci characteristics. Overall, we present a combined experimental and computational framework for studying how dynamic changes in fibroblast subpopulations lead to tissue-level disease phenotypes. Author SummaryIn wound healing fibroblasts are responsible for rebuilding the scaffolding, called the extracellular matrix (ECM), of the damaged tissue to aid in regeneration. In fibrosis, the normal wound healing processes are hijacked leading to overproduction of ECM proteins, such as collagen, by fibroblasts leading to fibrosis. In fibrotic diseases with no known cause, such as idiopathic pulmonary fibrosis (IPF), subpopulations of fibroblasts have been identified as possible drivers of disease. Herein, we use a multiscale computational model that represents intracellular, cellular, and tissue level signaling to study how the presence or absence of a single protein on a fibroblasts surface, Thy-1, affects the formation of fibrotic scar in IPF. Thy-1 regulates how a fibroblast senses the stiffness of the microenvironment. The absence of Thy-1 impacted intracellular signaling and when combined across many cells led to fibrosis at the tissue level. Additionally, if normal Thy-1+ fibroblasts could dynamically lose Thy-1 expression the amount of collagen they produced correlated with that in end stage IPF lungs. This model presents a framework for studying different fibroblast subpopulations using multiscale computational modeling to understand how changes in a single protein in one cell can, over an entire population, affect the dynamics of disease progression.

bioengineering↗

An agent-based model suggests how senescent cell behavior and matrix mechanics drive pulmonary fibrosis in aged mice

Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disease of aging, driven by dysregulated fibroblast activation and accompanied by collagen accumulation in the lung interstitium, resulting in tissue stiffening. While the accumulation of senescent cells has been increasingly implicated in IPF pathogenesis, understanding the reciprocal dynamics of senescent fibroblast levels and evolving tissue mechanics is difficult to achieve with experimental approaches alone. To address this limitation, we developed an agent-based model (ABM) of fibroblast activation in the lung that couples cell behavior to the dynamic mechanical changes accompanying fibrosis. This model was parameterized entirely from experimental data in young mice to enable robust validation and then adapted to fit aged mouse biology for additional validation. Both young and aged models accurately reflected changes in collagen accumulation and stiffness burden of experimental systems. We then incorporated senescent cell behavior into the aged model to investigate how senescent cell burden influences fibrosis progression and how cell-cell interactions drive senescent cell accumulation. These simulations identified a unique role for juxtacrine-mediated contact between non-senescent and senescent fibroblasts in expanding the total senescent cell burden. Our ABM also revealed that the timing of immune-mediated senescent cell clearance critically regulates fibrotic outcomes. Together, this ABM provides useful insights into how the interrelated dynamics of tissue mechanics and senescent fibroblasts drive fibrosis progression.

bioengineering↗

Microporous annealed particle scaffolds avoid foreign body response by down regulating complement-fibroblast-macrophage signaling loop

Biomaterial implantation can trigger a foreign body response (FBR) that impedes tissue-implant integration. To investigate how implant porosity influences this response, we compared the immune response to subcutaneous implants of microporous annealed particle (MAP) scaffolds and nanoporous hydrogels using mass cytometry, single-cell RNA sequencing, and multiplex cytokine assays. MAP scaffolds promoted vascularization and tissue integration, marked by increased endothelial and regulatory T cells, and reduced proinflammatory immune cells and cytokines. In contrast, nanoporous hydrogels demonstrated enrichment of basophils, natural killer cells, and macrophage populations associated with fibrosis. Transcriptomic and proteomic analyses revealed that MAP scaffolds suppressed activation of the complement-fibroblast-macrophage signaling loop, particularly the C5a signaling crosstalk pathway. This was confirmed using C5-deficient mice, where complement-driven cytokine production was significantly reduced only in nanoporous implants. These findings demonstrate that scaffold porosity modulates immune and complement responses, identifying a key mechanism by which MAP scaffolds reduce FBR and improve biomaterial integration.

bioengineering↗

IgA antibodies against oxidation-specific epitopes are generated by double negative B cells and are associated with impaired lung function in fibrotic interstitial lung diseases.

BackgroundFibrotic interstitial lung diseases (fILD) are characterized by progressive scarring of the lung and high mortality. Oxidation-specific epitopes (OSEs) form on oxidized lipids and proteins, are abundant in lungs of patients with fILD and perpetuate lung injury and fibrosis in animal models. OSE-targeting antibodies bind to OSEs and modulate their downstream effects. The objective of this study was to determine the association of OSE-targeting antibodies with lung function and other clinical outcomes, and to characterize OSE-specific B cell phenotypes in fILD. MethodsTo determine the association of OSE-targeting antibodies and clinical outcomes in fILD, we measured plasma levels of OSE-specific antibodies against the malondialdehyde modified LDL mimotope P1 and anti-ApoB100 immune complex (anti-ApoB100 IC) in patients with fILD and age-matched controls. We then performed B cell phenotyping of patients with idiopathic pulmonary fibrosis (IPF) and healthy controls utilizing mass cytometry time of flight (CyTOF). To investigate effects of pro-fibrotic mediators on anti-OSE IgA antibody production, we measured B cell responses to OSEs in vitro. ResultsCohort of 109 patients with fILD (Hypersensitivity Pneumonitis, Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia, Connective Tissue Disease-Associated Interstitial Lung Disease) and 55 healthy donors, and a second cohort of 20 patients with IPF and 9 healthy donors were included in the study. OSE-specific antibody levels anti-P1 and anti-ApoB100 IC IgA and IgG were significantly elevated in participants with fILD compared to healthy donors (p<0.0001). Higher anti-OSE IgA was associated with worse baseline lung function, including forced vital capacity (FVC) (p<0.001) and diffusing capacity for carbon monoxide (DLCO) (p<0.01). IgA+CD27-CD21-CD11c+ double negative type 2 (DN2) B cells correlated with anti-OSE IgA levels (p<0.05) and were enriched in OSE-specific cells. DN2 B cell precursors, CXCR5-CD11c+ naive B cells and IgA+CD27-CD21-CD11c- DN3 B cells, were significantly expanded in IPF compared to healthy donors. Both DN2 and DN3 B cells correlated with plasmablast pools in IPF patients and showed high baseline levels of IL-21 receptor, which was reduced in more differentiated cells. TGF-{beta} combined with OSEs, but not OSEs alone, induced OSE-specific IgA production in vitro. ConclusionsCirculating anti-OSE IgA antibodies are elevated in patients with fibrotic ILDs regardless of underlying pathology and negatively correlate with lung function. These antibodies correlated with the DN2 B cell subset which was enriched in OSE-specific cells. Phenotypic analysis of B cell subsets showed expression of markers consistent with DN to plasmablast differentiation. Finally, TGF-{beta} promoted OSE-IgA production in vitro. These findings show a novel link between oxidative tissue damage, anti-OSE antibodies and DN2 B cells in fILD which may provide opportunities for new targeted therapies.

immunology↗

Lung tissue viscoelasticity is preserved with bleomycin-induced fibrosis in mice

In pulmonary fibrosis, excessive scar tissue accumulates in the alveolar interstitial space, impairing gas exchange and compromising lung function. This fibrotic remodeling results in tissue stiffening, but more complex lung mechanical properties critical to tissue function, such as viscoelasticity and stress relaxation, remain poorly defined. To address this gap, we use the bleomycin aged mouse model to characterize both bulk and spatially-resolved viscoelastic mechanical properties of normal and fibrotic lungs. Our analysis reveals that while bleomycin-induced fibrosis leads to heterogeneously increased lung stiffness, viscoelasticity as measured by tan delta (ratio of loss to storage modulus) and stress relaxation timescales remains remarkably consistent as a function of both age and bleomycin treatment. This unexpected preservation of viscoelasticity despite fibrotic stiffening highlights a previously underappreciated mechanical phenotype of fibrotic lungs. To model these distinct mechanical features in vitro, we utilize a hyaluronic acid-based hydrogel system that largely recapitulates the viscoelastic mechanical properties observed in both normal and fibrotic lungs. These findings provide new insight into the mechanical consequences of fibrosis and establish a tunable in vitro hydrogel platform mimicking key tissue viscoelastic properties.

bioengineering↗

Novel wheat germ agglutinin-based mass cytometry cell barcoding reagent for heterogeneous, live or fixed sample

Sample multiplexing in flow cytometry is a powerful technique which allows for reduction of error, inclusion of control samples for batch effect correction, and reduction in both time and consumable usage. Current industry standard for barcoding in mass cytometry is an intracellular reagent, which requires fixation and permeabilization of sample prior to barcoding. We developed a barcode using the ubiquitous and well-tolerated membrane labeling lectin, wheat germ agglutinin. This barcode effectively labels all tested cell types, both live and fixed. We determine that barcode yields, or the ratio of debarcoded cells to total input cells, is stable in live pooled sample for at least an hour. This barcode does not show differential performance across major PBMC lineages. Thus, this universal wheat germ agglutinin-based barcode represents an advance in gentle, non-reactive cell surface barcoding for live cells.

cell biology↗

A protective role for B-1 cells and oxidation-specific epitope IgM in lung fibrosis

Idiopathic pulmonary fibrosis (IPF) is a morbid fibrotic lung disease with limited treatment options. The pathophysiology of IPF remains poorly understood, and elucidation of the cellular and molecular mechanisms of IPF pathogenesis is key to the development of new therapeutics. B-1 cells are an innate B cell population which play an important role linking innate and adaptive immunity. B-1 cells spontaneously secrete natural IgM and prevent inflammation in several disease states. One class of these IgM recognize oxidation-specific epitopes (OSE), which have been shown to be generated in lung injury and to promote fibrosis. A main B-1 cell reservoir is the pleural space, adjacent to the typical distribution of fibrosis in IPF. In this study, we demonstrate that B-1 cells are recruited to the lung during injury where they secrete IgM to OSE (IgMOSE). We also show that the pleural B-1 cell reservoir responds to lung injury through regulation of the chemokine receptor CXCR4. Mechanistically we show that the transcription factor Id3 is a novel negative regulator of CXCR4 expression. Using mice with B-cell specific Id3 deficiency, a model of increased B-1b cells, we demonstrate decreased bleomycin-induced fibrosis compared to littermate controls. Furthermore, we show that mice deficient in secretory IgM (sIgM-/-) have higher mortality in response to bleomycin-induced lung injury, which is partially mitigated through airway delivery of the IgMOSE E06. Additionally, we provide insight into potential mechanisms of IgM in attenuation of fibrosis through RNA sequencing and pathway analysis, highlighting complement activation and extracellular matrix deposition as key differentially regulated pathways.

immunology↗

Evaluation of K18-hACE2 mice as a model of SARS-CoV-2 infection

Abstract/SummaryMurine models of SARS-CoV-2 infection are critical for elucidating the biological pathways underlying COVID-19 disease. Because human ACE2 is the receptor for SARS-CoV-2, mice expressing the human ACE2 gene have shown promise as a potential model for COVID-19. Five mice from the transgenic mouse strain K18-hACE2 were intranasally inoculated with SARS-CoV-2 Hong Kong/VM20001061/2020. Mice were followed twice daily for five days and scored for weight loss and clinical symptoms. Infected mice did not exhibit any signs of infection until day four, when weight loss, but no other obvious clinical symptoms were observed. By day five all infected mice had lost around 10% of their original body weight, but exhibited variable clinical symptoms. All infected mice showed high viral titers in the lungs as well as altered lung histology associated with proteinaceous debris in the alveolar space, interstitial inflammatory cell infiltration and alveolar septal thickening. Overall, these results show that symptomatic SARS-CoV-2 infection can be established in the K18-hACE2 transgenic background and should be a useful mouse model for COVID-19 disease.

pathology↗